[The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion]

Med Clin (Barc). 2013 Dec 7;141(11):507.e1-507.e10. doi: 10.1016/j.medcli.2013.09.002. Epub 2013 Oct 26.
[Article in Spanish]

Abstract

The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most frequent cause of hyponatremia in a hospital setting. However, detailed protocols and algorithms for its management are lacking. Our objective was to develop 2 consensus algorithms for the therapy of hyponatremia due to SIADH in hospitalized patients. A multidisciplinary group made up of 2 endocrinologists, 2 nephrologists, 2 internists, and one hospital pharmacist held meetings over the period of a year. The group worked under the auspices of the European Hyponatremia Network and the corresponding Spanish medical societies. Therapeutic proposals were based on widely-accepted recommendations, expert opinion and consensus guidelines, as well as on the authors' personal experience. Two algorithms were developed. Algorithm 1 addresses acute correction of hyponatremia posing as a medical emergency, and is applicable to both severe euvolemic and hypovolemic hyponatremia. The mainstay of this algorithm is the iv use of 3% hypertonic saline solution. Specific infusion rates are proposed, as are steps to avoid or reverse overcorrection of serum sodium levels. Algorithm 2 is directed to the therapy of SIADH-induced mild or moderate, non-acute hyponatremia. It addresses when and how to use fluid restriction, solute, furosemide, and tolvaptan to achieve eunatremia in patients with SIADH. Two complementary strategies were elaborated to treat SIADH-induced hyponatremia in an attempt to increase awareness of its importance, simplify its therapy, and improve prognosis.

Keywords: Algorithm; Algoritmo; Consenso; Consensus; Encefalopatía hiponatrémica; Hiponatremia; Hipoosmolalidad plasmática; Hyponatremia; Hyponatremic encephalopathy; Plasma hyposmolality; Syndrome of inappropriate antidiuretic hormone secretion; Síndrome de secreción inadecuada de vasopresina; Tolvaptan; Tolvaptán.

Publication types

  • Consensus Development Conference
  • Practice Guideline

MeSH terms

  • Acute Disease
  • Algorithms
  • Benzazepines / therapeutic use
  • Combined Modality Therapy
  • Decision Support Techniques
  • Fluid Therapy / methods
  • Furosemide / therapeutic use
  • Humans
  • Hyponatremia / etiology
  • Hyponatremia / therapy*
  • Inappropriate ADH Syndrome / complications*
  • Infusions, Intravenous
  • Saline Solution, Hypertonic / therapeutic use
  • Severity of Illness Index
  • Tolvaptan

Substances

  • Benzazepines
  • Saline Solution, Hypertonic
  • Tolvaptan
  • Furosemide